Viagraf Dbm Paste
Filler, Bone Void, Osteoinduction (W/O Human Growth Factor). 510(k) K043209, from Osteotech, Inc. (Eatontown, NJ). Product code MBP, class 2.
As of Nov 18, 2026, K043209 is an FDA 510(k) held by Osteotech, Inc., substantially equivalent on Dec 5, 2005 after 381 days, with no recalls tied to it in FDA's recall database.
- Review time: 381 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFVIAGRAF$^{\diamond}$ DBM Paste is intended for use in filling bony voids or gaps of the extremities that are not intrinsic to the stability of the bony structure. The voids or gaps may be surgically created defects or defects created by traumatic injury to the bone. VIAGRAF$^{\diamond}$ DBM Paste is resorbed/remodeled and is replaced by host bone during the healing process.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Exactech Resorbable Bone PasteK020078 · Exactech, Inc. · Feb 27, 2004
- Exactech Resorbable Room Temperature Bone PasteK040755 · Exactech, Inc. · Jun 17, 2004
- Allomatrix Model# 86K020895 · Wrightmedicaltechnologyinc · Mar 5, 2004
Other MBP clearances
The newest 510(k)s for the same product code; see every MBP device- PliaFX FloK242799 · Lifenet Health · Nov 21, 2024
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 19, 2004
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3045
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files